We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

FTC finalizes rule extending reporting requirements for pharmaceutical patent transfers

Robert F. Leibenluft

Robert F. Leibenluft,

Washington, D.C.

Lauren E. Battaglia

Lauren E. Battaglia,

Washington, D.C.

Michele S. Harrington

Michele S. Harrington,

Northern Virginia

Joseph G. Krauss

Joseph G. Krauss,

Washington, D.C.

Leigh Oliver

11 November 2013
On 6 November 2013 the Federal Trade Commission (FTC) announced final changes to certain Hart-Scott-Rodino (HSR) rules regarding acquisitions of exclusive patent rights in the pharmaceutical industry. The revised rules, which apply only to transfers of pharmaceutical patent rights, will increase the number of licensing arrangements in the pharmaceutical industry that will be subject to the HSR Act’s pre-closing filing and waiting period requirements.
FTC finalizes rule extending reporting requirements for pharmaceutical patent transfers

Read more here.

Robert F. Leibenluft

Robert F. Leibenluft,

Washington, D.C.

Lauren E. Battaglia

Lauren E. Battaglia,

Washington, D.C.

Michele S. Harrington

Michele S. Harrington,

Northern Virginia

Joseph G. Krauss

Joseph G. Krauss,

Washington, D.C.

Leigh Oliver

Loading data